Terminated PHASE4 INTERVENTIONAL 2-arm NCT00922714

Scandinavian Intensive Care Unit (ICU) Glutamine Study

Glutamine to Intensive Care Patients - a Prospective, Double-Blind, Placebo-Controlled Multicenter Study in the Scandinavian Countries

Sponsor: Scandinavian Critical Care Trials Group

Conditions ICU Patients

Interventions Glutamine saline (placebo)

Updated 4 times since 2017 Last updated: Jun 15, 2009 Started: Oct 31, 2003 Primary completion: May 31, 2007 Completion: Aug 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow recruitment, stopped after 4 years

A PHASE4 clinical study on ICU Patients, this trial is terminated or withdrawn. The trial is conducted by Scandinavian Critical Care Trials Group and has accumulated 4 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2017 — Jan 2021 [monthly]

Terminated PHASE4

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scandinavian Critical Care Trials Group

Data source: Scandinavian Critical Care Trials Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden